mConsent to Resell iCoreRx Cloud ePrescribing Solution by iCoreConnect

August 6, 2024

https://www.globenewswire.com/news-release/2024/08/05/2924286/0/en/mConsent-to-Resell-iCoreRx-Cloud-ePrescribing-Solution-by-iCoreConnect.html

Strategic Partnership Enhances Patient Engagement Platform with Advanced iCoreRx ePrescribing Software

OCOEE, FL, Aug. 05, 2024 (GLOBE NEWSWIRE) — iCoreConnect Inc. (NASDAQ:ICCT) (“iCore” or the “Company”), a leading cloud-based software and technology company, today announced a new reseller agreement with mConsent, a leader in digital patient intake, patient communication and engagement solutions. Through this partnership, mConsent will now offer iCoreConnect’s premier electronic prescribing software, iCoreRx, as part of its suite of digital solutions.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.